In recent trading session, Elanco Animal Health Inc (NYSE:ELAN) saw 0.75 million shares changing hands at last check today with its beta currently measuring 1.67. Company’s recent per share price level of $14.78 trading at $0.27 or 1.90% at last check today assigns it a market valuation of $7.34B. That most recent trading price of ELAN’s stock is at a discount of -6.77% from its 52-week high price of $15.78 and is indicating a premium of 45.74% from its 52-week low price of $8.02. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.21 million shares which gives us an average trading volume of 5.80 million if we extend that period to 3-months.
For Elanco Animal Health Inc (ELAN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.60. Splitting up the data highlights that, out of 5 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Elanco Animal Health Inc (NYSE:ELAN) trade information
Upright in the green today for gaining 1.90%, in the last five days ELAN remained trading in the red while hitting it’s week-highest on Tuesday, 07/15/25 when the stock touched $14.78 price level, adding 1.79% to its value on the day. Elanco Animal Health Inc’s shares saw a change of 10.75% in year-to-date performance and have moved -1.70% in past 5-day. Elanco Animal Health Inc (NYSE:ELAN) showed a performance of 5.68% in past 30-days. Number of shares sold short was 24.28 million shares which calculate 4.03 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 11.5 to the stock, which implies a fall of -28.52% to its recent value today. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would jump 25.58% in reaching the projected high whereas dropping to the targeted low would mean a gain of 25.58% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.95% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -7.39% while estimates for its earnings growth in next 5 years are of 6.42%.
Elanco Animal Health Inc (NYSE:ELAN)’s Major holders
Insiders are in possession of 1.03% of company’s total shares while institution are holding 101.48 percent of that, with stock having share float percentage of 102.54%. Investors also watch the number of corporate investors in a company very closely, which is 101.48% institutions for Elanco Animal Health Inc that are currently holding shares of the company. DODGE & COX is the top institutional holder at ELAN for having 83.58 million shares of worth $1.21 billion. And as of 2024-06-30, it was holding 16.9128 of the company’s outstanding shares.
The second largest institutional holder is PRIMECAP MANAGEMENT CO/CA/, which was holding about 52.8 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.6845 of outstanding shares, having a total worth of $761.94 million.
On the other hand, Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 55.34 shares of worth $816.56 million or 11.14% of the total outstanding shares. The later fund manager was in possession of 18.91 shares on Mar 31, 2025 , making its stake of worth around $279.08 million in the company or a holder of 3.81% of company’s stock.
